206 related articles for article (PubMed ID: 15705367)
21. Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial.
Baker VL; Fujimoto VY; Kettel LM; Adamson GD; Hoehler F; Jones CE; Soules MR
Fertil Steril; 2009 Apr; 91(4):1005-11. PubMed ID: 18367182
[TBL] [Abstract][Full Text] [Related]
22. Recombinant LH supplementation to recombinant FSH during the final days of controlled ovarian stimulation for in vitro fertilization. A multicentre, prospective, randomized, controlled trial.
NyboeAndersen A; Humaidan P; Fried G; Hausken J; Antila L; Bangsbøll S; Rasmussen PE; Lindenberg S; Bredkjaer HE; Meinertz H;
Hum Reprod; 2008 Feb; 23(2):427-34. PubMed ID: 18024487
[TBL] [Abstract][Full Text] [Related]
23. Small doses of LH activity are needed early in ovarian stimulation for better quality oocytes in IVF-ET.
Drakakis P; Loutradis D; Kallianidis K; Liapi A; Milingos S; Makrigiannakis A; Dionyssiou-Asteriou A; Michalas S
Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):77-80. PubMed ID: 15989987
[TBL] [Abstract][Full Text] [Related]
24. Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study.
Schachter M; Friedler S; Ron-El R; Zimmerman AL; Strassburger D; Bern O; Raziel A
Fertil Steril; 2008 Oct; 90(4):1087-93. PubMed ID: 18023439
[TBL] [Abstract][Full Text] [Related]
25. Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization.
Schmidt DW; Maier DB; Nulsen JC; Benadiva CA
Fertil Steril; 2004 Oct; 82(4):841-6. PubMed ID: 15482757
[TBL] [Abstract][Full Text] [Related]
26. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
[TBL] [Abstract][Full Text] [Related]
27. A comparison of 3-day and daily follicle-stimulating hormone injections on stimulation days 1-6 in women undergoing controlled ovarian hyperstimulation.
Scholtes MC; Schnittert B; van Hoogstraten D; Verhoeven HC; Zrener A; Warne DW
Fertil Steril; 2004 Apr; 81(4):996-1001. PubMed ID: 15066454
[TBL] [Abstract][Full Text] [Related]
28. A randomized controlled dose-response pilot study of addition of hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilization.
Thuesen LL; Loft A; Egeberg AN; Smitz J; Petersen JH; Andersen AN
Hum Reprod; 2012 Oct; 27(10):3074-84. PubMed ID: 22791754
[TBL] [Abstract][Full Text] [Related]
29. The effect of LH supplementation to the GnRH antagonist protocol in advanced reproductive ageing women: a prospective randomized controlled study.
Younis JS; Izhaki I; Ben-Ami M
Clin Endocrinol (Oxf); 2016 Jan; 84(1):99-106. PubMed ID: 26304041
[TBL] [Abstract][Full Text] [Related]
30. Comparison of daily and alternate day recombinant follicle-stimulating hormone stimulation protocols for intrauterine insemination.
Kabli N; Sylvestre C; Tulandi T; Buckett W
Fertil Steril; 2009 Apr; 91(4):1141-4. PubMed ID: 18342857
[TBL] [Abstract][Full Text] [Related]
31. Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization.
Kovacs P; Kovats T; Bernard A; Zadori J; Szmatona G; Kaali SG
Fertil Steril; 2008 Dec; 90(6):2133-7. PubMed ID: 18177866
[TBL] [Abstract][Full Text] [Related]
32. Elevated day 3 follicle-stimulating hormone/luteinizing hormone ratio >or= 2 is associated with higher rates of cancellation in in vitro fertilization-embryo transfer cycles.
Liu KE; Greenblatt EM
Fertil Steril; 2008 Aug; 90(2):297-301. PubMed ID: 18023434
[TBL] [Abstract][Full Text] [Related]
33. Controlled ovarian stimulation with exclusive FSH followed by stimulation with hCG alone, FSH alone or hMG.
Gomes MK; Vieira CS; Moura MD; Manetta LA; Leite SP; Reis RM; Ferriani RA
Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):99-106. PubMed ID: 16835006
[TBL] [Abstract][Full Text] [Related]
34. [Results of application of high daily doses of recombinant follicle stimulating hormone in different age groups of women in IVF program].
Tsagareishvili GG; Khonelidze NL; Lazarev AP
Georgian Med News; 2005 Jun; (123):7-12. PubMed ID: 16052045
[TBL] [Abstract][Full Text] [Related]
35. The effect of recombinant LH on embryo quality: a randomized controlled trial in women with poor ovarian reserve.
Musters AM; van Wely M; Mastenbroek S; Kaaijk EM; Repping S; van der Veen F; Mochtar MH
Hum Reprod; 2012 Jan; 27(1):244-50. PubMed ID: 22095792
[TBL] [Abstract][Full Text] [Related]
36. Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization.
Fornaro F; Cobellis L; Mele D; Tassou A; Badolati B; Sorrentino S; De Lucia D; Colacurci N
Fertil Steril; 2007 Jan; 87(1):39-47. PubMed ID: 17084393
[TBL] [Abstract][Full Text] [Related]
37. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
[TBL] [Abstract][Full Text] [Related]
38. Recombinant luteinizing hormone priming in multiple follicular stimulation for in-vitro fertilization in downregulated patients.
Lisi F; Caserta D; Montanino M; Berlinghieri V; Bielli W; Carfagna P; Carra MC; Costantino A; Lisi R; Poverini R; Ciardo F; Rago R; Marci R; Moscarini M
Gynecol Endocrinol; 2012 Sep; 28(9):674-7. PubMed ID: 22313135
[TBL] [Abstract][Full Text] [Related]
39. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
[TBL] [Abstract][Full Text] [Related]
40. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain.
Burgués S;
Hum Reprod; 2001 Dec; 16(12):2525-32. PubMed ID: 11726569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]